Those that used aspirin after their colon cancer diagnosis were found to have improved rates of both cancer-specific and overall survival, according to a new study from Norway.
Previous studies and trials have suggested that aspirin could reduce risk of colon cancer, but these studies have been debated due to risk of cerebral and gastrointestinal bleeding.
This puzzle led Sumer Bains, MD, to assess the use of the drug after diagnosis. Bains and her colleagues studied over 25,000 people diagnosed with colon cancer, some of which identified as aspirin-users and some which did not.
After two years of follow-up, 34.2% of aspirin-exposed patients had died compared to 38.9% of the patients that did not use aspirin. This suggests that aspirin could be associated with improved rates of survival.
Other News from Around the Web:
- Researchers have been using a new mouse model to test cancer cells because it better imitates how cancer cells spread in the human body.
- Colon cancer patient Will Lanier bares all to raise awareness for the disease.
- New research is emerging regarding over-the-counter therapies for colon cancer.
- Increased number of doctor visits may be related to colon cancer diagnosis, according to new research.